The "http://www.fundaciondexeus.org/" Fundación Dexeus Salud de la Mujer has awarded 1 of the 5 grants of the VIII Grant Call for Clinical Research Projects 2013 to Dr. Eva Colàs, researcher at the Translational Research Unit and Pediatric Oncology of Vall d'Hebron Research Institute (VHIR), for the study "Development of predictive algorithms of risk of recurrence and response to therapy in endometrial cancer". The aid amount is 6,000 euros.The recognized project aims to develop tools for predicting response alternatives to endometrial cancer, such as biomedical algorithms and / or nomograms to improve the classification of the disease, and thus benefit patients not responding to therapy with more aggressive treatment and a stricter observation. According to Dr. Colàs, the application of these nomograms in clinical practice "will improve the survival of patients who currently have a high risk of recurrence".Because endometrial cancer is a highly incident disease and is still considered a good prognosis cancer, mortality is now comparable to that of such devastating diseases such as ovarian cancer. Despite the establishment of a protocol of adjuvant consensus treatment, researchers from VHIR have observed that the high mortality rate associated with this cancer comes from patients with advanced diagnostics, ie, when the disease has already spread outside the cavity, and patients diagnosed with non-endometrioid histologies. Therefore, Dr. Colàs concludes that "current patterns of patient classification versus adjuvant treatment who will receive and / or adjuvant treatment received by patients, are not effective to cure them".